Crossmark

Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience

Crossref DOI link: https://doi.org/10.1186/s13287-020-01981-4

Published Online: 2020-10-28

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fang, Gang

Jiang, Xiaolang

Fang, Yuan

Pan, Tianyue

Liu, Hao

Ren, Bichen

Wei, Zheng

Gu, Shiyang

Chen, Bin

Jiang, Junhao

Shi, Yun

Guo, Daqiao

Liu, Peng

Fu, Weiguo

Dong, Zhihui https://orcid.org/0000-0002-3754-2458
Funding

Funding for this research was provided by:

China National Natural Science Funds (81970407)

Training program for outstanding academic leaders of Shanghai health and family planning system (2018BR40)

The Program of Shanghai Academic Research Leader (19XD1401200)

The Training Project for “Future Star” Doctor of Fudan University
License Information

Text and Data Mining valid from 2020-10-28

Version of Record valid from 2020-10-28
More Information

Article History

Received: 20 August 2020

Accepted: 19 October 2020

First Online: 28 October 2020

Ethics approval and consent to participate

: The study design was approved by the Ethics Committee of Zhongshan Hospital, Fudan University, Shanghai, China. All included patients were informed about the nature of the study and gave their written informed consent.

: All patients signed a consent form for their data to be used for research or publication.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below